|The US Food and Drug Administration (FDA) finally approved the new antipsychotic drug lumateperone (Caplyta, from Intra-Cellular Therapies, Inc) on December 23, 2019 for treatment of schizophrenia in adults, in spite of previously canceling its review because of mixed results in testing, which were blamed on positive responses to placebos.|
As with other antipsychotics, lumateperone includes a boxed warning that elderly patients with dementia-related psychosis are at an increased risk for death.
Also as with other antipsychotics, the mechanism of action is unknown — they’re just guessing about how it is supposed to “work.” It plays Russian Roulette with serotonin, dopamine and glutamate (another neurotransmitter) in the brain.
It has all the usual possible side effects – neuroleptic malignant syndrome, tardive dyskinesia, hyperglycemia, diabetes, weight gain, sedation, increased risk of falls, seizures, infertility, etc. Newborns exposed to antipsychotic drugs during the third trimester of pregnancy may suffer withdrawal symptoms.
Since cytochrome P450 enzymes such as CYP3A4 are involved in its metabolism in the liver, a person’s genetic abnormality with these can lead to the drug or its metabolites reaching a toxic level in hours or days, correlating with the onset of severe side effects. One is also ill-advised to drink grapefruit juice with this drug because it strongly inhibits the CYP3A4 enzyme, again increasing the risk of serious adverse reactions.
Of course, psychiatrists attribute any attempts at suicide to the underlying diagnosis and not to the drugs.
Speaking of the Underlying Diagnosis
Today, psychiatry clings tenaciously to antipsychotics as the treatment for “schizophrenia,” despite their proven risks and studies which show that when patients stop taking these drugs, they improve.
The late Professor Thomas Szasz stated that “schizophrenia is defined so vaguely that, in actuality, it is a term often applied to almost any kind of behavior of which the speaker disapproves.”
These are normal people with medical, disciplinary, educational, ethical or spiritual problems that can and must be resolved without recourse to drugs. Deceiving and drugging is not the practice of medicine. It is criminal.
Any medical doctor who takes the time to conduct a thorough physical examination of a child or adult exhibiting signs of what a psychiatrist calls Schizophrenia can find undiagnosed, untreated physical conditions. Any person labeled with so-called Schizophrenia needs to receive a thorough physical examination by a competent medical—not psychiatric—doctor to first determine what underlying physical condition is causing the manifestation.
Any person falsely diagnosed as mentally disordered which results in treatment that harms them should file a complaint with the police and professional licensing bodies and have this investigated. They should seek legal advice about filing a civil suit against any offending psychiatrist and his or her hospital, associations and teaching institutions seeking compensation.
No one denies that people can have difficult problems in their lives, that at times they can be mentally unstable, subject to unreasonable depression, anxiety or panic. Mental health care is therefore both valid and necessary. However, the emphasis must be on workable mental healing methods that improve and strengthen individuals and thereby society by restoring people to personal strength, ability, competence, confidence, stability, responsibility and spiritual well–being. Psychiatric drugs and psychiatric treatments are not workable.
For more information, click here to download and read the full CCHR report “Schizophrenia—Psychiatry’s For Profit ‘Disease’“.
An attacker killed eight students and injured two others with a cleaver (NOT a gun) at an elementary school in Chaoyangpo village of Enshi city in the Hubei province of central China on September 3, 2019.
“China tightly restricts private gun ownership, making knives and homemade explosives the most common weapons in violent crimes.”
The attacker was released in June, 2018, after serving more than eight years in jail for attempted murder. We aren’t sure about China, but in the U.S. prison inmates are regularly dosed with dangerous psychiatric drugs known to cause violence and suicide.
As of this writing, the case is still under investigation and no motive has been found for the attacks. Not much additional information is available, so speculation abounds. Our own speculation is that the attacker was most probably given psychiatric drugs while incarcerated, drugs which are known to cause violence and suicide.
We do know that China’s Ministry of Public Security uses psychiatric involuntary commitment to remove dissidents from society.
“Given the enormous increases in psychiatric drug sales in China, there is little doubt that the pharmaceutical industry has landed a lucrative market, driven by a psychiatric community willing to deliberately politicize psychiatric labeling.”
Under China’s current system of compulsory mental health treatment, people can be sent to asylums for treatment against their will by blood relatives or spouses, and forcibly given harmful psychiatric drugs.
It has also been well documented that psychiatric torture occurs inside Chinese prisons, often conducted with the goal of securing a confession, even though the Chinese government has officially made obtaining confessions through the use of torture illegal.
Let’s just aim for the right target and get the actual data, shall we? At least in the U.S. we can contact our government officials and urge them to hold legislative hearings to fully investigate the correlation between psychiatric drugs, violence, and suicide. The U.S. Food and Drug Administration, representing the U.S. government’s interest in protecting citizens from harmful drugs, already says that antidepressants increase the risk of suicidal thinking and behavior; children and adolescents who are started on antidepressants should be observed closely for clinical worsening, suicidality, agitation, irritability, or unusual changes in behavior. And keep those meat cleavers away from kids on Prozac.
The U.S. Food & Drug Administration (FDA) has known for years that there are increased risks of suicidal thinking and behavior (suicidality) in both adults and children taking antidepressants.
Over the years there has been a steady loosening of these warnings, as drug manufacturers lobbied to have the warnings relaxed.
But as can be observed in current news media reports, incidences of violence and suicide by both adults and chidren taking or withdrawing from these psychiatric drugs has apparently been increasing.
Most of these drugs are not even approved for use by children.
A study reported in the British Medical Journal cites statistics showing that, “It can no longer be doubted that antidepressants are dangerous and can cause suicide and homicide at any age.”
Acts of criminal violence have been with us since time immemorial but what we have been witnessing over the last couple of decades staggers the mind and assaults the senses. These grotesque acts, devoid of any possible sense of moral decency, strike us as completely incomprehensible—-mothers blowing the brains out of their small children, fathers slashing their young children to pieces, employees “calmly” walking through their offices or factories murdering their co-workers, and young children going on maniacal shooting sprees in school yards.
As each new incident is reported, we sit in stunned horror and wonder what is happening to our way of life.
How can we be at the dawn of the twenty-first century with technology hurtling us into a space age future and yet continue to find ourselves without a solution to the escalating number of acts of random, senseless violence? The reason is that we have been fed all manner of wrong reasons for why these tragedies have taken place and so they continue.
It is not guns that are the common denominator to these horrific events—-some occur with knives, axes and even automobiles. Nor is it clothing, age, gender or political orientation. The fact missed by most is that psychiatric, mind-altering drugs have been found to be the common factor in an overwhelming number of these acts of random senseless violence. These drugs, on an ever increasing rise in society and amongst schoolchildren, particularly over the last two decades, are actually creating acts of violence.
Find out by downloading and reading the CCHR report “Psychiatric Drugs Create Violence & Suicide — School Shootings & Other Acts of Senseless Violence.”
Introduced by Republican Missouri Senator Josh Hawley, the “Supporting and Treating Officers In Crisis Act of 2019” (S. 998) was signed into law by President Trump on July 25, 2019.
This bill reauthorizes and expands certain Department of Justice grant programs to provide mental health, stress reduction, psychological services, suicide prevention services, and training for identifying, reporting, and responding to officer mental health crises and suicide, for law enforcement officers and their families. The bill authorizes up to $7,500,000 in appropriations each year for fiscal years 2020 to 2024, a maximum total of $37.5 million.
This sounds eminently socially acceptable, and indeed the bill was widely supported by Congress and various national advocacy groups.
The Real Crisis in Mental Health
While society certainly owes significant consideration and support to law enforcement officers (LEOs) and their families, we can’t help noting that in today’s environment, “mental health and suicide prevention services” really means psychiatric drugs and other harmful psychiatric treatments.
While the bill specifically calls for evidence-based programs, the evidence actually shows that psychiatrists don’t know what causes mental trauma, are unable to predict violence or suicide, and cannot cure any mental disorder they claim to treat.
By their own admission psychiatrists cannot predict violence or suicide, and often release violent patients from facilities, claiming that they are not a threat. In 1979, an American Psychiatric Association’s task force admitted in its Brief Amicus Curiae to the U.S. Supreme Court that psychiatrists could not predict dangerousness. It informed the court that “‘dangerousness’ is neither a psychiatric nor a medical diagnosis, but involves issues of legal judgment and definition, as well as issues of social policy.” In addition to not being able to predict violent behavior, psychiatrists certainly have no cures for it, a fact that even they admit.
Psychiatric diagnoses are not based on science, but opinion. Psychiatrists do not have any scientific or medical test to diagnose a person’s mental condition and rely upon faulty observation and opinion of behavior. They admit to not knowing the cause of a single mental disorder or how to cure them. The error in their opinions is enormous — they condemn the innocent, release the dangerous, induce violence in others through drugs and commit people who are not in need of help or turn those away who may genuinely be in need of it.
Rather than training psychiatrists and psychologists about LEO mental health, the grants should be used to train LEOs, security personnel, teachers, coroners, and other professionals to recognize that irrational, violent and suicidal behavior could be caused by psychiatric drugs.
Click here to download and read the CCHR report “Psychiatric Drugs Create Violence & Suicide — School Shootings & Other Acts of Senseless Violence.”
Click here to download and read “Psychiatrists Cannot Predict or Cure Violence.“
“Antidepressant-induced akathisia-related homicides associated with diminishing mutations in metabolizing genes of the CYP450 family”
by Yolande Lucire and Christopher Crotty
Pharmacogenomics and Personalized Medicine, 1 August 2011
This research paper details patients who had been referred to Dr. Lucire’s practice for expert opinion or treatment. More than 120 subjects were diagnosed with akathisia [a neurotoxic psychosis often characterized by a feeling of inner restlessness and inability to stay still] or serotonin toxicity [extremely high levels of serotonin causing toxic and potentially fatal effects] after taking psychiatric drugs that had been prescribed for psychosocial distress. Akathisia has been known to be associated with suicide since the 1950s and with homicide since 1985.
They were tested for variant alleles in cytochrome P450 (CYP450) genes, which play a major role in the metabolism of all antidepressant and many other drugs, indicating ultrarapid metabolism due to allele duplications. This seems to be strongly associated with a large number of deaths from intoxication and suicide. High or fast-changing levels of psychotropic substances can cause unpredictable toxicity leading to violent behavioral effects, including akathisia. [An allele is one of two or more alternative forms of a gene that arise by mutation and are found at the same place on a chromosome.]
Psychiatric drugs are metabolized in the liver by cytochrome P450 enzymes in order to be eliminated from the body. Abnormal CYP450 metabolism, either ultrarapid and/or diminished, can lead to the drug or its metabolites reaching a toxic level in hours or days, correlating with the onset of intense dysphoria [unease or generalized dissatisfaction with life] and akathisia. A person genetically deficient in these enzymes, or who has an ultrarapid drug metabolism, or who is taking other (legal or illegal) drugs that diminish CYP450 enzyme activity, is at risk of a toxic accumulation of the drug leading to more severe side effects.
Eight of these cases had committed homicide and many more became extremely violent or suicidal while on antidepressants. Ten representative case histories involving serious violence are presented in great detail in the paper. None of the ten subjects described had any history of mental illness; none had been violent before. All recovered from akathisia after stopping the medication without assistance or supervision and, frequently, against medical advice.
Akathisia suicides and homicides, particularly when they involved children, gave rise to the first antidepressant suicide advisories by the FDA in 2004.
Personal, medical, and legal problems can arise from using psychiatric drugs and experiencing the resulting toxicity from these metabolic effects. The results presented in this paper demonstrate the grave extent to which the psychiatric industry has expanded its influence beyond its ability to cure.
As the authors state, “In all of the cases presented here, the subjects were prescribed antidepressants that failed to mitigate distress emerging from their predicaments, which encompassed psychosocial stressors such as bereavement, marital and relationship difficulties, and work-related stress. Every subject’s emotional reaction worsened while their prescribing physicians continued the “trial and error” approach, increasing from standard to higher dose and/or switching to other antidepressants, with disastrous consequences. In some cases the violence ensued from changes occasioned by withdrawal and polypharmacy. In all of these cases, the subjects were put into a state of drug-induced toxicity manifesting as akathisia, which resolved only upon discontinuation of the antidepressant drugs.”
“It is the authors’ contention that prescribing antidepressants without knowing about CYP450 genotypes is like giving blood transfusions without matching for ABO groups [the classification of human blood].”
In general, the psychiatric industry pushes psychotropic drugs without regard to these CYP450 cautions, but this is the direct result of the unscientific psychiatric diagnoses perpetrated by the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) which fraudulently justifies prescribing these harmful drugs for profit in the first place.
1. Practice Full Informed Consent by asking your doctor for information about possible side effects and benefits, ways to treat side effects, and risks of other conditions, as well as information about alternative treatments.
2. If your doctor diagnoses a mental disorder and prescribes a psychiatric drug, ask to see the clinical lab tests proving the diagnosis. (There won’t be any.)
3. All treatment options should include checking for real underlying medical conditions that could cause a patient’s mental or emotional duress.
4. Write your state and federal legislators to establish rights for patients and their insurance companies to receive refunds for mental health treatment which did not achieve the promised result or improvement, or which resulted in proven harm to the individual, thereby ensuring that responsibility lies with the individual practitioner and psychiatric facility rather than the government or its agencies.
6. Patients, doctors and insurance companies should report all instances of adverse side effects from psychiatric drugs to the FDA.
7. The pernicious influence of psychiatry has wreaked havoc throughout society, especially in hospitals, educational systems and prisons. Citizens groups and responsible government officials should work together to expose and abolish psychiatry’s hidden manipulation of society for profit.
Kratom is an increasingly popular drug of abuse and readily available on the “recreational” drug market. Between 3 million and 5 million people in the U.S. use kratom, and reported poisonings from people taking it have soared.
The U.S. Food and Drug Administration (FDA) has warned against using Mitragyna Speciosa, commonly known as kratom, a tree in the coffee family which grows naturally in Thailand, Malaysia, Indonesia, Philippines, Vietnam, Myanmar, and Papua New Guinea. The concern is that kratom leaves, which affect the same opioid brain receptors as morphine, appear to have properties that expose users to the risks of addiction, abuse, and dependence.
There are no FDA-approved uses for kratom because there is no scientific evidence to support its medical use, and the FDA urges consumers to report any adverse reactions to the FDA’s MedWatch program.
Because kratom is still legal in the U.S., it has become a go-to drug for individuals with chronic pain, promoted anecdotally by some psychiatrists both to mitigate pain and to ease withdrawal from other opioids.
Some other psychiatrists are convinced of kratom’s mental health benefits as a potential therapeutic agent.
Similar to the dose-dependent characteristics of any drug, in relatively small amounts kratom acts as a stimulant; in relatively larger amounts it causes sedation; and when overdosed it can cause death.
Kratom’s psychoactive compounds, mitragynine and 7-hydroxymitragynine, are opioid-receptor agonists, which means they are chemicals that bind to the same receptors in the brain to which opioids bind, thus acting in the brain similar to other opioids like morphine and codeine.
Side effects of taking (or withdrawing from) kratom may include dependence, nausea, vomiting, aggression, hallucinations, delusions, psychosis, seizures, thyroid problems, increased risk of suicide, trouble breathing, brain swelling, seizures, liver damage, or death.
In spite of the American Kratom Association’s lobbying efforts to promote this harmful substance, and its repeated references to the American Psychiatric Association for support, we find that there is sufficient reason to be highly skeptical.
Click here for more information about kratom.
[Reference: “Multiple adverse outcomes following first discharge from inpatient psychiatric care: a national cohort study”, The Lancet Psychiatry, June 03, 2019]
“People discharged from inpatient psychiatric care are at higher risk than the rest of the population for a range of serious fatal and non-fatal adverse outcomes.”
These individuals are also more likely to perpetrate violent crimes, including homicide. Suicide risk is known to be especially raised soon after discharge.
Results were summarized from 62,922 Danish people who had been discharged from inpatient psychiatric services and 1,573,050 who had never been a psychiatric inpatient, examining these adverse outcomes over ten years post-discharge: mortality, suicide, accidental death, homicide victimization, homicide perpetration, non-fatal self-harm, violent criminality, and hospitalization following violence.
The risk of at least one of these adverse outcomes was highest in people using psychoactive drugs.
Although no detailed clinical information was available regarding what psychiatric treatments were given, it can be assumed that psychiatric (psychoactive) drugs were a major part of most treatments, since worldwide statistics show that a rapidly increasing percentage of every age group, from children to the elderly, rely heavily and routinely on psychiatric drugs in their daily lives. Worldwide sales of antidepressants, for example, were more than $14 billion in 2017, and expected to surpass $15 billion by 2023.
These statistics give one more result in a long line of significant research that concludes:
- psychiatry cannot cure any so-called mental illness
- psychiatric treatments cause violence and suicide
- psychiatric treatments actually harm rather than help vulnerable people
- psychiatry is junk science
- psychiatric drugs can only chemically mask problems and symptoms; they cannot and never will be able to solve problems
People in desperate circumstances must be provided proper and effective medical care. Medical, not psychiatric, attention, good nutrition, a healthy, safe environment and activity that promotes confidence will do far more than the brutality of psychiatry’s treatments.
While life is full of problems, and sometimes those problems can be overwhelming, it is important for you to know that psychiatry, its diagnoses and its drugs are the wrong way to go.
A new report (“St. Louis Regional Mental Health Data Report“, May, 2019) outlines mental health trends in the St. Louis, Missouri region.
The St. Louis County Department of Public Health and the City of St. Louis Department of Health prepared the report for System of Care St. Louis Region.
One significant finding is that “…intentional self-harm (i.e., suicide) was the sixth leading cause of death for children under 18 years of age and the third leading cause of death for ages 18 to 24 years in St. Louis County, and it is the tenth leading cause of death for all age groups in both the United States and the state of Missouri.”
Unfortunately, the report fails to notice that there is overwhelming evidence that psychiatric drugs cause suicide and violence.
While there is never one simple explanation for what drives a human being to commit such unspeakable acts of violence, all too often one common denominator has surfaced in hundreds of cases—-prescribed psychiatric drugs which are documented to cause mania, psychosis, violence, suicide and in some cases, homicidal ideation. To date, there has been no federal investigation of the link between psychiatric drugs and acts of suicide and violence.
Mental disorder is not a predictor of aggressive behavior, but rather the adverse effects of the drugs prescribed to treat it. Drug proponents argue that there are many shootings and acts of violence that have not been correlated to psychiatric (psychotropic) drugs, but that is exactly the point. It has neither been confirmed nor refuted, as law enforcement is not required to investigate or report on prescribed drugs linked to suicide and violence, and media rarely pose the question.
Those with a vested, financial interest will continue to champion the use of such drugs, as the psychiatric-pharmaceutical drug industry rakes in an average of $35 billion a year in sales in the U.S. alone. It is that vested financial interest which may be preventing a thorough investigation of the link between prescription psychoactive drugs and increased suicide and violence, especially considering that there have been calls for such investigations since the Columbine High School massacre in 1999.
The theory that a person is violent because he “stopped taking his medication” is misleading and omits the fact that it is more likely to be the withdrawal from a drug of dependence that is experienced—-not the return of the person’s “untreated mental illness.” Numerous studies and expert opinions support this. Psychotropic drug withdrawal destroys mental faculties and creates impulsivity.
It is long past time that government agencies answered that call with an investigation. Legislative hearings should be held to fully investigate the correlation between psychiatric treatment and violence and suicide. None can argue against the fact that disclosure of the facts would serve the public interest.
Click here for more information about the link between suicide, violence, and psychiatric drugs.
Abilify Mycite® (aripiprazole tablets with sensor, from Otsuka Pharmaceutical) is a prescription drug of an aripiprazole tablet (an atypical antipsychotic) with a metallic Ingestible Event Marker (IEM) sensor inside it, used in adults for diagnoses of schizophrenia, bipolar I disorder, and major depressive disorder. A month’s supply of it costs around $1,650. The actual mechanism of action of aripiprazole is unknown, although it messes with the levels of dopamine and serotonin in the brain, which is playing Russian Roulette with your mind.
The sensor is intended to track, with a smartphone app, if the drug has been taken. The ability of this drug to improve patient compliance or modify dosage has not been established. The only thing the FDA approved was functions related to tracking drug ingestion. The use of this drug to track drug ingestion in real-time or during an emergency is not recommended because detection may be delayed or not occur.
The drug sends information to a patch worn on the patient’s arm, which is then logged on a mobile app, which then sends the data to their doctor. Some experts warn that the idea of swallowing a tracking chip may be too much for paranoid patients to handle.
Said one expert, “I am concerned about the formation of new pharmaceutical persons who are digitally enhanced to be compliant with the profit motives of corporations and the directives of health providers and drug companies. … The fact that the drug is Abilify, which is prescribed to people who experience serious mental distress, should raise many ethical red flags. These concerns are especially relevant because the patent for the original Abilify drug expired in 2016… My concern is that … the company will be motivated to profit from the technology as much as possible, regardless of whether the drug actually improves health.”
The idea for this gross invasion of privacy comes about because refusing to take prescribed drugs is a particular psychiatric concern, and is even enshrined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) as “Nonadherence to medical treatment.”
Abilify MyCite is still not widely used in the US, possibly because of skepticism from patients, prescribing doctors and insurance providers, although Otsuka has collaborated with Magellan Health to roll the drug out to the US, and UnitedHealthcare has developed complex rules for insurance authorization.
This drug has potentially severe side effects including stroke; akathisia; neuroleptic malignant syndrome; tardive dyskinesia; unusual urges such as compulsive gambling, sex, eating, or shopping; seizures; suicidal thoughts or behaviors. Side effects may be considerably more severe with known CYP2D6 poor metabolizers (a Cytochrome P450 enzyme.)
This drug also has a Boxed Warning about an increased risk of suicidal thinking and behavior in children, adolescents and young adults.
Recognize that the real problem is that psychiatrists fraudulently diagnose life’s problems as an “illness”, and stigmatize unwanted behavior as “diseases.” Psychiatry’s stigmatizing labels, programs and treatments are harmful junk science; their diagnoses of “mental disorders” are a hoax — unscientific, fraudulent and harmful.
If you are taking this drug, do not stop suddenly. You could suffer serious withdrawal symptoms. You should seek the advice and help of a competent medical doctor or practitioner before trying to come off any psychiatric drug.
Recently there has been a gross increase in the TV ad campaign for Chantix, promoting this deadly drug for smoking cessation.
We’ve written about Chantix before, but we thought a repeat was in order due to this massive ad campaign.
In 2008 the Federal Aviation Administration banned Chantix for pilots and air traffic controllers, and reissued that decision in 2013.
The U.S. Food and Drug Administration (FDA) slapped a “Black Box” warning on Chantix (varenicline tartrate, made by Pfizer) in 2009 after receiving thousands of reports linking the drug to mental health issues, including suicidal thoughts, hostility and agitation.
In 2015, the FDA expanded the warning to note that the drug had also been linked to reduced alcohol tolerance leading to seizures.
However, in 2016 the FDA removed the Black Box warning, after heavy lobbying from Pfizer claiming that additional data showed that the benefits of Chantix outweighed its adverse side effects (oh, and since its sales had significantly dropped.)
But the adverse side effects did not go away; only the Black Box warning went away. One study found that Chantix had more cases of suicidal thoughts, self-harm, and homicidal thoughts than any other drug, by a more than three-fold margin. Pfizer’s prescribing information still warns about new or worsening mental health problems such as changes in behavior or thinking, aggression, hostility, agitation, depressed mood, or suicidal thoughts or actions while taking or after stopping Chantix.
We suspect that the recent spate of TV ads is related to the removal of the Black Box warning and the prior drop in sales. Also, the price of Chantix more than doubled between 2013 and 2018. In 2013, Pfizer paid out $273 million to settle a majority of the 2,700 state and federal lawsuits that had been filed over adverse side effects. Now the company is trying to grow the market with clinical studies for smokers age 12 to 19.
What is Chantix?
Chantix is a psychiatric drug — a benzodiazepine-based anti-anxiety drug, also called a minor tranquilizer or sedative hypnotic. Daily use of therapeutic doses of benzodiazepines are associated with physical dependence, and addiction can occur after 14 days of regular use. Typical consequences of withdrawal are anxiety, depression, sweating, cramps, nausea, psychotic reactions and seizures. There is also a “rebound effect” where the individual experiences even worse symptoms than they started with as a result of chemical dependency.
The exact mechanism of action of benzodiazepines is not known, but they affect neurotransmitters in the brain and suppress the activity of nerves, under the unproven theory that excessive activity of nerves may be the cause of anxiety. Chantix was developed to specifically affect nicotinic receptors in the brain, under the theory that this would reduce nicotine craving and block the rewarding effects of smoking. Messing with neurotransmitters in the brain is playing Russian Roulette with your mind.
Benzodiazepines are metabolized by cytochrome P450 enzymes, so a genetic lack of these enzymes can cause a buildup of harmful toxins and increase the severity of adverse side effects.
Psychiatric “best practices” consider that smoking is an addiction and recommend that psychiatrists assess tobacco use at every patient visit, since tobacco addiction is covered in the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) as a “mental illness” under eight separate items, and disorders related to inhalant use have 33 entries. Smoking is not a mental illness and addiction cannot be fixed with psychiatric drugs.
The psychiatric industry considers that smoking cessation therapies are their territory, however this drug masks the real cause of problems in life and debilitates the individual, thus denying one the opportunity for real recovery and hope for the future. Treating substance abuse with drugs is a major policy blunder; contact your state and federal representatives and let them know you disapprove of this trend.
Recognize that the real problem is that psychiatrists fraudulently diagnose life’s problems as an “illness”, and stigmatize unwanted behavior like smoking as a “disease.” Psychiatry’s stigmatizing labels, programs and treatments are harmful junk science; their diagnoses of “mental disorders” are a hoax — unscientific, fraudulent and harmful. All psychiatric treatments, not just psychiatric drugs, are dangerous.